Definition of the binding mode of phosphoinositide 3-kinase α-selective inhibitor A-66S through molecular dynamics
Xiaoli Bian1, Wangqing Dong, Yang Zhao
1Department of Pharmacy, College of Medicine, Xi'an Jiaotong University, No. 76 Yanta west Road, Xi'an, 710061, People's Republic of China.
Abstract:
Activation of the phosphatidylinositol 3-kinase α (PI3Kα) is commonly observed in human cancer and is critical for tumor progression, which has made PI3Kα an attractive target for anticancer drug discovery. To systematically investigate the binding mode of A-66S, a new selective PI3Kα inhibitor for PI3Kα, molecular docking, molecular dynamics simulation and ensuing energetic analysis were performed. The binding free energy between PI3Kα and A-66S is -11.27 kcal•mol⁻¹ using MMPBSA method, while -14.67 kcal•mol⁻¹ using MMGBSA method, which is beneficial for the binding, and the van der Waals/hydrophobic and electrostatic interactions are critical for the binding. The conserved hydrophobic adenine region of PI3Kα made up of Met772, Pro778, Ile800, Tyr836, Ile848, Val850, Val851, Met922, Phe930 and Ile932 accommodates the flat 2-tert-butyl-4'-methyl-4,5'-bithiazol moiety of A-66S, and the NH of Val851 forms a hydrogen with the nitrogen atom embedded in the aminothiazole ring of A-66S. The (S)-pyrrolidine carboxamide urea moiety especially extends toward the region of the binding site wall (Ser854-Gln859) defined by the C-terminal lobe, and has three hydrogen-bond arms with the backbone of Ser854 and the side chain of Gln859. Notably the interaction between the non-conserved residue Gln859 and A-66S is responsible for the selectivity profile of A-66S. The binding mode of A-66S for PI3Kα presented in this study should aid in the design of a new highly selective PI3Kα inhibitor.
Insights
This study reveals how A-66S, a selective phosphatidylinositol 3-kinase alpha (PI3Kα) inhibitor, binds to PI3Kα. Key hydrophobic and hydrogen-bond interactions, particularly with Gln859, drive its potent and selective anticancer activity.
Area of Science:
- Biochemistry
- Molecular Biology
- Drug Discovery
Background:
- Phosphatidylinositol 3-kinase alpha (PI3Kα) activation is crucial for cancer progression.
- PI3Kα is a significant target for developing novel anticancer therapeutics.
Purpose of the Study:
- To elucidate the binding mode of A-66S, a selective PI3Kα inhibitor.
- To understand the molecular interactions responsible for A-66S's efficacy and selectivity.
Main Methods:
- Molecular docking simulations.
- Molecular dynamics (MD) simulations.
- Energetic analysis using MMPBSA and MMGBSA.
Main Results:
- A-66S exhibits strong binding affinity to PI3Kα, with binding free energies of -11.27 kcal•mol⁻¹ (MMPBSA) and -14.67 kcal•mol⁻¹ (MMGBSA).
- Hydrophobic and electrostatic interactions are critical for binding, involving the adenine region of PI3Kα and the bithiazol moiety of A-66S.
- Specific hydrogen bonds and interactions with non-conserved residue Gln859 contribute to A-66S's selectivity for PI3Kα.
Conclusions:
- The detailed binding mode of A-66S to PI3Kα has been characterized.
- Understanding these interactions can guide the design of more potent and selective PI3Kα inhibitors for cancer therapy.
More Related Videos
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
14:34A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
Published on: April 3, 2026
Related Concept Videos
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
The Equilibrium Binding Constant and Binding Strength
Protein-Drug Binding: Mechanism and Kinetics
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
The JAK-STAT Signaling Pathway
